v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 9,820 $ 12,365
Marketable securities 3,046 16,365
Trade accounts receivable, net 6,513 6,412
Other current assets 1,961 4,189
Total current assets 21,340 39,331
Property and equipment, net 1,104 1,040
Intangibles, net 17,045 22,191
Goodwill 9,056 8,532
Lease right of use assets 3,238 3,659
Other assets 1,175 1,013
Total assets 52,958 75,766
Liabilities, Current [Abstract]    
Accounts payable and other accrued liabilities 4,359 5,118
Deferred revenue 3,993 4,020
Total current liabilities 8,352 9,138
Long-term lease liabilities 4,314 5,213
Other long-term liabilities 63 56
Total liabilities 12,729 14,407
Commitments and contingencies (Note 17)
Shareholders’ equity:    
Preferred stock (par value $0.001 per share, 2,500 authorized, 10 shares issued and outstanding at December 31, 2025 and December 31, 2024) 50 50
Common stock (par value $0.001 per share, 50,000 authorized, 21,901 and 21,495 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively) 22 21
Additional paid-in capital 424,665 415,049
Accumulated deficit (383,087) (350,778)
Accumulated other comprehensive loss (1,421) (2,983)
Total shareholders’ equity 40,229 61,359
Total liabilities and shareholders’ equity $ 52,958 $ 75,766